# K142449: Headway 27 Microcatheter

- Pathway: 510(k) (Special)
- Applicant: MicroVention, Inc.
- Decided: Mar 26, 2015 after 205 days
- Product code: DQY (Catheter, Percutaneous)
- Device class: 2
- Regulation: 21 CFR 870.1250
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 6 generations back to K960806 (1996). 7 ancestors in all.
5 later devices descend from it; 2 cite it directly.
0 of 13 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K110813: Headway 27 Microcatheter, MicroVention, Inc. (2011) Summary page 4.

## Most influential descendants
- K192625: PG Pro Microcatheter (2019), 3 descendants of its own
- K231600: SENDERO Microcatheter (2023), 2 descendants of its own
- K240384: SENDERO Microcatheter (2024), 1 descendant of its own
- K242644: SENDERO MAX Delivery Catheter (2024), 0 descendants of its own
- K213314: CerusEndo Microcatheter (027) (2022), 0 descendants of its own

## Indications for use
The Headway Microcatheter is intended for general intravascular use, including the peripheral, coronary and neuro vasculature for the infusion of diagnostic agents, such as contrast media, and therapeutic agents, such as occlusion coils.

Source page: https://510kreport.com/device/K142449
Methodology: https://510kreport.com/methodology